Peritoneal debulking/intraperitoneal chemotherapy - Non-sarcoma Journal Article

  


Authors: Kelly, K. J.; Nash, G. M.
Article Title: Peritoneal debulking/intraperitoneal chemotherapy - Non-sarcoma
Abstract: The combination of cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) is widely practiced for appendiceal, colorectal, gastric, and ovarian cancers with isolated peritoneal metastasis as well as for primary peritoneal cancer. The aim of this report is to explain the rationale and available techniques for CRS and IPC, and to highlight disease-specific considerations that should be taken into account when evaluating potential candidates for CRS and IPC. J. Surg. Oncol. 2014 109:14-22. © 2013 Wiley Periodicals, Inc. © 2013 Wiley Periodicals, Inc.
Keywords: cytoreductive surgery; early postoperative intraperitoneal chemotherapy (epic); hyperthermic intraperitoneal chemotherapy (hipec)
Journal Title: Journal of Surgical Oncology
Volume: 109
Issue: 1
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2014-01-01
Start Page: 14
End Page: 22
Language: English
DOI: 10.1002/jso.23449
PROVIDER: scopus
PUBMED: 24166680
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84890556194&partnerID=40&md5=bdbe2e4bcc1798c6c2f8b2443a14dd97
Notes: Export Date: 2 January 2014 -- CODEN: JSONA -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Kaitlyn J Kelly
    31 Kelly
  2. Garrett Nash
    263 Nash
Related MSK Work